Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors

dc.contributor.authorErbilgin, Yucel
dc.contributor.authorEskazan, Ahmet Emre
dc.contributor.authorNg, Ozden Hatirnaz
dc.contributor.authorSalihoglu, Ayse
dc.contributor.authorElverdi, Tugrul
dc.contributor.authorFirtina, Sinem
dc.contributor.authorTasar, Orcun
dc.contributor.authorMercan, Sevcan
dc.contributor.authorSisko, Sinem
dc.contributor.authorKhodzhaev, Khusan
dc.contributor.authorOngoren, Seniz
dc.contributor.authorAr, Muhlis Cem
dc.contributor.authorBaslar, Zafer
dc.contributor.authorSoysal, Teoman
dc.contributor.authorSayitoglu, Muge
dc.contributor.authorOzbek, Ugur
dc.date.accessioned2025-10-16T15:24:26Z
dc.date.issued2019
dc.identifier.doi10.1080/10428194.2018.1473573
dc.identifier.otherWOS:000458399900024
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8108
dc.publisherTAYLOR \& FRANCIS LTD
dc.sourceLEUKEMIA \& LYMPHOMA
dc.subjectChronic myeloid leukemia
dc.subjectnext\\-generation sequencing
dc.subjectdrug resistance
dc.subjecttyrosine kinase inhibitor
dc.titleDeep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors
dc.typeArticle

Dosyalar

Koleksiyonlar